Search Result "empagliflozin"


Review Article

Empagliflozin and the Diabetic Kidney: Pathophysiological Concepts and Future Challenges

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 0 Year: 2021 Page: 1-39
Author(s): Georgios S. Papaetis

Case Report

Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature

Journal: Current Diabetes Reviews
Volume: 15 Issue: 4 Year: 2019 Page: 259-262
Author(s): Carlos Hernandez-Quiles,Nieves Ramirez-Duque,Domingo Acosta-Delgado

A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2015 Page: 105-112
Author(s): Saad Hussain Syed, Sucheta Gosavi, Waseem Shami, Marco Bustamante, Zul Farah, Muhammad Teleb, Aamer Abbas, Sarmad Said, Debabrata Mukherjee

Research Article

Comparative Study of Different Derivative Spectrophotometric Techniques for the Analysis and Separation of Metformin, Empagliflozin, and Glimepiride

Journal: Current Pharmaceutical Analysis
Volume: 16 Issue: 7 Year: 2020 Page: 916-934
Author(s): Khanda F.M. Amin,Nabil A. Fakhre,Ahmed M. Abdullah

Research Article

Standardizing the Effective Correlated Dosage of Olanzapine and Empagliflozin in Female Wistar Rats

Journal: Current Gene Therapy
Volume: 21 Issue: 1 Year: 2021 Page: 52-58
Author(s): Ghulam Md Ashraf,Badrah S. Alghamdi,Fahad S. Alshehri,Mohammad Z. Alam,Haythum O. Tayeb,Frank I. Tarazi

Review Article open access plus

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Journal: Current Diabetes Reviews
Volume: 13 Issue: 4 Year: 2017 Page: 405-423
Author(s): Matthew J. Levine

Commentary

Resistance to Diuretics in Heart Failure: Any Role for Empagliflozin?

Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 421-424
Author(s): Niki Katsiki,Filippos Triposkiadis

Review Article

Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes

Journal: Current Diabetes Reviews
Volume: 14 Issue: 6 Year: 2018 Page: 509-517
Author(s): Molly G. Minze,Kayley J. Will,Brian T. Terrell,Robin L. Black,Brian K. Irons

Review Article

Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 1 Year: 2017 Page: 1522-1532
Author(s): Niki Katsiki,Dimitri P. Mikhailidis,Michael J. Theodorakis

Previous   Next

Go To   Results 1 - 1 of 127

Filter Result

Volume Year
Ads
© 2022 Bentham Science Publishers | Privacy Policy